Dr. Anja Roden, MD

• Anatomic & Clinical Pathology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Mayo Clinic

  Fellowship Hospital, 2009

• Mayo Clinic

  Residency Hospital, 2008

• Tu Dresden

  Medical School, 1992

• MicroRNA-mRNA interactions in a murine model of hyperoxia-induced bronchopulmonary dysplasia, 2012-05-30

• EZH2 and POU2F3 Can Aid in the Distinction of Thymic Carcinoma from Thymoma, 2023-04-13

• DARPP-32 and t-DARPP promote non-small cell lung cancer growth through regulation of IKKa-dependent cell migration, 2018-05-03

• A Prospective, Multi-Institutional Assessment of Four Assays for PD-L1 Expression in NSCLC by Immunohistochemistry, 2017-08-01

• CD117, BAP1, MTAP, and TdT Is a Useful Immunohistochemical Panel to Distinguish Thymoma from Thymic Carcinoma, 2022-05-05

• IASLC Global Survey on PD-L1 Testing for Non-Small Cell Lung Cancer, 2021-03-02

• Correlation of Somatostatin Receptor 2 Expression, 68Ga-DOTATATE PET Scan and Octreotide Treatment in Thymic Epithelial Tumors, 2022-02-07

• B7-H1 expression in malignant pleural mesothelioma is associated with sarcomatoid histology and poor prognosis, 2014-04-24

• Dopamine D2 Receptor Agonists Inhibit Lung Cancer Progression by Reducing Angiogenesis and Tumor Infiltrating Myeloid Derived Suppressor Cells, 2014-08-30

• Selective YAP/TAZ Inhibition in Fibroblasts via Dopamine Receptor D1 Agonism Reverses Fibrosis, 2019-10-30

• Localized malignant mesothelioma, an unusual and poorly characterized neoplasm of serosal origin: best current evidence from the literature and the International Mesothelioma Panel, 2019-09-04

• ASCL1-regulated DARPP-32 and t-DARPP stimulate small cell lung cancer growth and neuroendocrine tumour cell proliferation, 2020-06-05

• IASLC MULTIDISCIPLINARY RECOMMENDATIONS FOR PATHOLOGIC ASSESSMENT OF LUNG CANCER RESECTION SPECIMENS FOLLOWING NEOADJUVANT THERAPY, 2020-01-28

• Surgery for Mesothelioma After Radiation Therapy (SMART); A Single Institution Experience, 2020-03-24

• An integrative histopathologic clustering model based on immuno-matrix elements to predict the risk of death in malignant mesothelioma, 2020-05-11

• Prospective multi-institutional evaluation of pathologist assessment of PD-L1 assays for patient selection in triple negative breast cancer, 2020-04-16

• The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee, 2020-06-06

• Reliability of histopathologic diagnosis of fibrotic interstitial lung disease: an international collaborative standardization project, 2021-06-01

• Reanalysis of the NCCN PD-L1 companion diagnostic assay study for lung cancer in the context of PD-L1 expression findings in triple-negative breast cancer, 2019-06-13

• A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee, 2020-06-17